FIV infection of IL-2-dependent and -independent feline lymphocyte lines: Host cells range distinctions and specific cytokine upregulation

Veterinary Immunology and Immunopathology

Volumn 65, Issue 2-4, 1998, Pages 277-297

  Lerner, Danica L ^a   Grant, Chris K ^b   De Parseval, Aymeric ^a   Elder, John H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Custom Monoclonals International   (United States)

Author keywords

Chemokine; Cytokine upregulation; FIV; MHC class II

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; CAT; CONFERENCE PAPER; CONTROLLED STUDY; FELINE LEUKEMIA VIRUS; GLIA CELL; HOST CELL; KIDNEY CELL; LYMPHOMA CELL LINE; MONONUCLEAR CELL; NONHUMAN; T LYMPHOCYTE; VIRUS INFECTION;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CATS; CELL LINE; CYTOKINES; DNA; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNODEFICIENCY VIRUS, FELINE; INTERLEUKIN-2; KIDNEY; LYMPHOMA, T-CELL; MOLECULAR SEQUENCE DATA; NEUROGLIA; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; UP-REGULATION;

EID: 0032561275     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(98)00162-7     Document Type: Conference Paper

References (41)

1. Ackley C.D., Yamamoto J.K., Levy N., Pedersen N.C., Cooper M.D. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J. Virol. 64:1990;5652-5655.
2. Benveniste O., Vaslin B., Le Grand R., Cheret A., Matheux F., Theodoro F., Cranage M.P., Dormont D. Comparative interleukin (IL-2)/interferon IFN-gamma and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SICmac251 virus. Proc. Natl. Acad. Sci. USA. 93:1996;3658-3663.
3. Bleul C.C., Wu L., Hoxie J.A., Springer T.A., Mackay C.R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T-lymphocytes. Proc. Natl. Acad. Sci, USA. 94:1997;1925-1930.
4. Breen E.C., Salazar-Gonzalez J.F., Shen L.P., Kolberg J.A., Urdea M.S., Martinez-Maza O., Fahey J.L. Circularing CD8 T-cells show increased interferon-gamma mRNA expression in HIV infection. Cell. Immunol. 178:1997;91-98.
5. + T-lymphocytes. J. Virol. 65:1991;3359-3364.
6. Brunner D., Pedersen N.C. Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J. Virol. 63:1989;5483-5488.
7. Cantin, R.C., Fortin, J.-F., Lamontagne, G., Tremblay, M., 1997a. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J. Virol. 71, 1922-1930.
8. Cantin, R.C., Fortin, J.-F., Lamontagne, G., Tremblay, M., 1997b. The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells, Blood 90, 1091-1100.
9. Cheret A., Le Grand R., Caufour P., Dereuddre-Bosquet N., Matheux F., Neildez O., Theodoro F., Maestrali N., Benveniste O., Vaslin B., Dormont D. Cytokine mRNA expression in mononuclear cells from different tissues during acute SICmac251 infection of macaques. AIDS Res. Hum. Retroviruses. 12:1996;1263-1272.
10. de Parseval A., Lerner D.L., Borrow P., Willett B.J., Elder J.H. Blocking of FIV infection by a monoclonal antibody to CD9 is via inhibition of virus release, rather than interference with receptor binding. J. Virol. 71:1997;5742-5749.
11. Dean G.A., Reubel G.H., Moore P.F., Pedersen N.C. Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node. J. Virol. 70:1996;5165-5169.
12. Dean, G., Woo, J., LaVoy, A., Moore, P., Pedersen, N., 1997. Cytokine expression in feline lymphoid tissues in health and disease. (abstract), The 2nd International Feline Immunology Workshop, University of California, Davis, CA, section 2-2.
13. English R.V., Johnson C.M., Gebhard D.H., Tompkins M.B. In vivo lymphocyte tropism of feline immunodeficiency virus. J. Virol. 67:1993;5175-5186.
14. Fantuzzi L., Gessani S., Borghi P., Varano B., Conti L., Puddu P., Belardelli A. Induction of interleukin-12 (IL-12) by recombinant glycoprotein gp120 of human immunodeficiency virus type 1 in human monocytes/macropahges: Requirement of gamma interferon for IL-12 secretion. J. Virol. 70:1996;4121-4124.
15. Gunn-Moore, D.A., Caney, S.M.A., Gruffyd-Jones, T.J., Harbour, D.A., 1997. FIP- associated changed in cytokine mRNA associated changes in cytokine mRNA levels in vivo. (abstract), The 2nd International Feline Immunology Workshop, U.C., Davis, CA, section 2-13.
16. + cell numbers in cats with naturally acquired feline immunodeficiency virus infection. J. Virol. 66:1992;1484-1488.
17. Hosie M.J., Willett B.J., Dunsford T.H., Jarrett O., Neil J.C. A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor. J. Virol. 67:1993;1667-1671.
18. Hunt P., McConnell I. Variable expression of major histocompatibility complex class II in the domestic cat. Res. Vet. Sci. 59:1995;195-200.
19. Johnson D.A., Gautsch J.W., Sportsman R., Elder J.H. Improved technique utilizing non-fat dry milk for analysis of protein and nucleic acids transferred to nitrocellulose. Gene Analysis Techniques. 1:1984;3-8.
20. Kannagi M., Kiyotaki M., King N.W., Lord C.I., Letvin N.L. Simian immunodeficiency virus induces expression of class II major histocompatibility complex structures on infected target cells in vitro. J. Virol. 61:1987;1421-1426.
21. Lerner D.L., Wagaman P.C., Phillips T.R., Prospero-Garcia O., Henriksen S.J., Fox H.S., Bloom F.E., Elder J.H. Increased mutation frequency of FIV lacking functional deoxyuridine triphosphatase. Proc. Natl. Acad. Sci. USA. 92:1995;7480-7484.
22. Novotney C., English R.V., Housman J., Davidson M.G., Nasisse M.P., Jeng C.R., Davis W.C., Tompkins M.B. Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus. AIDS. 4:1990;1213-1218.
23. Ohno K., Watari T., Goitsuka R., Tsujimoto H., Hasegawa A. Altered surface antigen expression on peripheral blood mononuclear cells in cats infected with feline immunodeficiency virus. J. Vet. Med. Sci. 54:1992;517-522.
24. Phillips T.R., Talbott R.L., Lamont C., Muir S., Lovelace K., Elder J.H. Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol. 64:1990;4605-4613.
25. Picard L., Simmons G., Power C.A., Meyer A., Weiss R.A., Clapham P.R. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J. Virol. 71:1997;5003-5011.
26. Rideout B.A., Moore P.F., Pedersen N.C. Persistent upregulation of MHC class II antigen expression on T-lymphocytes from cats experimentally infected with feline immunodeficiency virus. Vet. Immunol. Immunopathol. 35:1992;71-81.
27. Rosenberg Y.J., Cafaro A., Brennen T., Greenhouse J.G., Villinger F., Ansari A.A., Brown C., McKinnon K., Bellah S., Yalley-Ogunro J., Elkins W.R., Gartner S., Lewis M.G. Virus-induced cytokines regulate circulating lymphocyte levels during primary SIV infections. Int. Immunol. 9:1997;703-712.
28. Siebert P.D., Larrik J.W. Competitive PCR. Nature. 359:1992;557-558.
29. Siebert P.D., Larrik J.W. PCR mimics: Competitive DNA fragments for use as internal standards in quantitive PCR. Biotechniques. 14:1993;244-249.
30. Speck R.F., Wehrly K., Platt E.J., Atchison R.E., Charo I.F., Kabat D., Chesebro B., Goldsmith M.A. Selective employment of chemokine receptors as human immunodeficiency virus type 21 co-receptors determined by individual amino acids within the envelope V3 loop. J. Virol. 71:1997;7136-7139.
31. Talbott R.L., Sparger E.E., Lovelace K.M., Fitch W.M., Pedersen N.C., Luciw P.A., Elder J.H. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 86:1989;5743-5747.
32. Tochikura T.S., Hayes K.A., Cheney C.M., Tanabe-Tochikura A., Rojko J.L., Mathes L.E., Olsen R.G. In vitro replication and cytopathogenicity of the feline immunodeficiency virus for feline T4 thymic lymphoma 3201 cells. Virology. 179:1990;492-497.
33. Torten M., Franchini M., Barlough J.E., George J.W., Mozes E., Lutz H., Pedersen N.C. Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J. Virol. 65:1991;2225-2230.
34. Thompson F.J., Elder J.H., Neil J.C. Cis- and trans-regulation of feline immunodeficiency virus: Identification of functional binding sites in the long terminal repeat. J. Gen. Virol. 75:1994;545-554.
35. Verschoor E.J., Boven L.A., Blaak H., van Vliet A.L., Horzinek M.C., de Ronde A. A single mutation within the V3 envelope neutralization doma of feline immunodeficiency virus determines its tropism for CRFK cells. J. Virol. 69:1995;4752-4757.
36. Waters A.K., de Parseval A.P., Lerner D.L., Elder J.H. The role of ORF2 in determining the host cell tropism of feline immunodeficiency virus. Virology. 215:1996;10-16.
37. Willett B.J., Hosie M.J., Dunsford T.H., Neil J.C., Jarrett O. Productive infection of T-helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4. AIDS. 5:1991;1469-1475.
38. Willett B.J., Hosie M.J., Jarrett O., Neil J.C. Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology. 81:1994;228-233.
39. Willett B.J., Picard L., Hosie M.J., Turner J.D., Adema K., Clapham P.R. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71:1997;6407-6415.
40. Xu, W., Charo, I.F., Greene, W.C., Goldsmith, M.A., 1996. Interleukin-2 activiates expression of the HIV co-receptor, CKR5. (abstract) The Third West Coast Retrovirus Meeting, p. 15.
41. Zou W., Lackner A.A., Simon M., Durand-Gasselin I., Galanaud P., Desrosiers R.C., Emilie D. Early cytokine and chemokine gene expression in lymph-nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J. Virol. 71:1997;1227-1236.